55 research outputs found
TEVAR and periscope graft technique to treatment of huge aneurysm of aortic isthmus: Case report
Introduction: Thoracic endovascular aortic repair (TEVAR) has revolutionized the treatment of thoracic aortic aneurysms. Innovative techniques as chimney and periscope grafts can improve the outcomes of procedure. Herein, we report a case in emergency of huge Thoracic aortic aneurism. Presentation of case: An 86-year-old male with hypertension, diabetes mellitus, was referred to our hospital for chest pain. CT-angiography showed a huge aneurysm of aortic isthmus with signs of rupture. The patient was considered unfit for open surgery and an endovascular approach was chosen. This patient underwent endovascular repair with TEVAR, using the periscope graft technique to preserve patency in left subclavian artery (LSA). Discussion: Symptomatic ischemia from LSA coverage has been reported to occur in only a modest 6–10% of patients and is often sacrificed with impunity given coverage rates between 10 and 50%. In this case reported the lack of revascularization of LSA increased the risk of neurological manifestations or stroke. Periscope technique is feasible and safe to maintain perfusion to the subclavian artery, with a 93% primary patency at 2 years. Conclusions: Our experience using TEVAR with periscope graft technique as solution to address thoracic aneurysm of aortic isthmus was feasible and safe
Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report
Introduction: COVID-19 is an infectious disease that has been associated not only with respiratory complications. The COVID-19 disease includes, also damage to other organ systems as well as coagulopathy. The present report describes a case of COVID-19 presenting with acute mesenteric ischemia (AMI) and subsequent acute limb ischemia (ALI). Presentation of case: An 84-years old hospitalized female patient presenting diabetes and recent COVID-19 reported acute onset of abdominal pain and typical findings of AMI. The CT-angiography confirmed the AMI secondary to a superior mesenteric artery (SMA) occlusion. The patient was managed through an endovascular approach using a SMA mechanical thrombectomy and stenting with a good result. Discussion: Treatment of this life-threatening condition includes surgical resection of the necrotic bowel, restoration of blood flow to the ischemic intestine and supportive measure - gastrointestinal decompression, fluid resuscitation, hemodynamic support. Endovascular management of AMI is preferred over the standard surgical approach due to a reduced mortality and morbidity rates. Imaging findings of intestinal necrosis, however, represent an indication for AMI surgical treatment with explorative laparotomy. Different endovascular solutions have been employed to address AMI including mechanical thrombectomy, local thrombolysis, and PTA-stenting. Conclusion: COVID-19 clinical presentation can be atypical, including gastrointestinal symptoms. If a first embolic event occurs, an aggressive anticoagulation treatment could be inefficient to reduce the risk of subsequent embolization events. The limited life expectancy of such revascularization procedures should orientate towards less invasive treatments
CT angiography for the assessment of EVAR complications: a pictorial review
Endovascular aneurysm repair (EVAR) is a minimally invasive treatment proposed as an alternative to open repair in patients with abdominal aortic aneurysms. EVAR consists in a stent-graft placement within the aorta in order to exclude the aneurysm from arterial circulation and reduce the risk of rupture. Knowledge of the various types of devices is mandatory because some stents/grafts are more frequently associated with complications. CT angiography is the gold standard diagnostic technique for preprocedural planning and postprocedural surveillance. EVAR needs long-term follow-up due to the high rate of complications. Complications can be divided in endograft device-related and systemic complications. The purpose of this article is to review the CT imaging findings of EVAR complications and the key features for the diagnosis
Effects of a cooling vest with sham condition on walking capacity in heat-sensitive people with Multiple Sclerosis
Purpose: Heat sensitivity is a common contraindication in people with Multiple Sclerosis (pwMS), and physical fatigue is one of the most frequently reported symptoms that can affect quality of life. Increases in body temperature may exacerbate fatigue and heat-related symptoms. Decreasing body temperature via cooling devices may mitigate disease symptoms and improve physical abilities and quality of life. This study evaluates the effects of a cooling vest with sham condition on walking capacity using a commercially-available cooling vest specifically designed for pwMS. Methods: A counter-balanced, cross-over design was used to assess the effects of a cooling vest (CryoVest Comfort, CryoInnov, France) (COLD) from a menthol-induced sham condition (CON) on ground walking time to exhaustion (Tex, s) and distance at exhaustion (Dex, m) in ambulatory pwMS. Secondary outcomes were heart rate (HR, bpm), thermal sensation (Tsens), skin chest (Tchest) and back (Tback) temperature. Results: Ten females with Multiple Sclerosis (59 \ub1 9\ua0years, EDSS 3.0\u20135.5) participated to the study. During COLD, pwMS walked significantly longer (1896 \ub1 602 vs. 1399 \ub1 404\ua0s, p < 0.001) and farther (1879 \ub1 539 vs. 1302 \ub1 318\ua0m, p < 0.001) than CON. Importantly, Tsens and HR at exhaustion were not significantly different between conditions, although Tchest ( 12\ua02.7 \ub1 1.8\ua0\ub0C, p < 0.01) and Tback ( 12\ua03.9 \ub1 1.8\ua0\ub0C, p < 0.001) were lower at volitional fatigue during COLD. Conclusion: The lightweight cooling vest improved total walking time and distance in heat-sensitive pwMS. These physiological improvements were likely due to feeling perceptually cooler in the COLD trial, compared to the corresponding point of fatigue in the CON condition
The Role of Early Revascularization and Biomarkers in the Management of Diabetic Foot Ulcers: A Single Center Experience
Diabetic neuropathy and Peripheral Arterial Disease (PAD) are the main etiological factors in foot ulceration. Herein, we report our experience of diabetic foot ulceration (DFU) management, with an analysis of the relationship between the rate of lower extremity amputation, in persons with infected DFU, after revascularization procedures performed to prevent major amputation. This study highlights the role of different biomarkers, showing their usefulness and potentiality in diabetic foot ulcer management, especially for the early diagnosis and therapy effectiveness monitoring. A retrospective analysis, from September 2016 to January 2021, of diabetic patients presenting diabetic foot with DFU, was performed. All patients were treated with at least one vascular procedure (endovascular, open, hybrid procedures) targeting PAD lesions. Outcomes measured were perioperative mortality and morbidity. Freedom from occlusion, primary and secondary patency, and amputation rate were registered. A total of 267 patients, with a mean age of 72.5 years, were included in the study. The major amputation rate was 6.2%, minor amputation rate was 17%. In our experience, extreme revascularization to obtain direct flow reduced the rate of amputations, with an increase in ulcer healing
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the most recently defined inflammatory demyelinating disease of the central nervous system (CNS). Over the last decade, several studies have helped delineate the characteristic clinical-MRI phenotypes of the disease, allowing distinction from aquaporin-4 (AQP4)-IgG-positive neuromyelitis optica spectrum disorder (AQP4-IgG+NMOSD) and multiple sclerosis (MS). The clinical manifestations of MOGAD are heterogeneous, ranging from isolated optic neuritis or myelitis to multifocal CNS demyelination often in the form of acute disseminated encephalomyelitis (ADEM), or cortical encephalitis. A relapsing course is observed in approximately 50% of patients. Characteristic MRI features have been described that increase the diagnostic suspicion (e.g., perineural optic nerve enhancement, spinal cord H-sign, T2-lesion resolution over time) and help discriminate from MS and AQP4+NMOSD, despite some overlap. The detection of MOG-IgG in the serum (and sometimes CSF) confirms the diagnosis in patients with compatible clinical-MRI phenotypes, but false positive results are occasionally encountered, especially with indiscriminate testing of large unselected populations. The type of cell-based assay used to evaluate for MOG-IgG (fixed vs. live) and antibody end-titer (low vs. high) can influence the likelihood of MOGAD diagnosis. International consensus diagnostic criteria for MOGAD are currently being compiled and will assist in clinical diagnosis and be useful for enrolment in clinical trials. Although randomized controlled trials are lacking, MOGAD acute attacks appear to be very responsive to high dose steroids and plasma exchange may be considered in refractory cases. Attack-prevention treatments also lack class-I data and empiric maintenance treatment is generally reserved for relapsing cases or patients with severe residual disability after the presenting attack. A variety of empiric steroid-sparing immunosuppressants can be considered and may be efficacious based on retrospective or prospective observational studies but prospective randomized placebo-controlled trials are needed to better guide treatment. In summary, this article will review our rapidly evolving understanding of MOGAD diagnosis and management
A single-center experience on below-the-knee endovascular treatment in diabetic patients
Diabetic ulceration of the foot is a major global
medical, social and economic problem and is the most
frequent end-point of diabetic complications. A
retrospective analysis from February 2017 to May
2019 of diabetic patients presenting below-the-knee
artery disease (PAD) was carried out. Only patients
treated with endovascular techniques as first choice
treatment were evaluated. Outcome measured was
perioperative mortality and morbidity. Freedom from
occlusion, secondary patency and amputation rate
were all registered. Additional maneuvers including
stenting or angioplasty with drug eluting balloon
(DEB) were reported. A total of 167 (101 male/66
female) patients with a mean age of 71 years were
included in the study. A Rutherford 3, 4, 5 and 6
categories were reported in 5, 7, 110 and 45 patients,
respectively. No perioperative mortality was reported.
Morbidity occurred in 4 (4.4%) cases and consisted of
pseudoaneurysm. Additional stenting during first
procedure was required in 7 (4%) patients, drug
eluting balloon was needed in 56 (33%) patients. At
1-year follow-up, estimated freedom from occlusion
and secondary patency was 70% and 80%
respectively. Major amputation rate was 2.4%, minor
amputation rate was 41.9%. In our experience,
extreme revascularization in search of distal direct
flow reduce the rate of amputations with an increase
in ulcer healing. New materials and techniques such
as drug eluting technology, used properly, can
improve outcome
Position Paper on Young Vascular Surgeons Training of the Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS):State of the Art and Perspectives
The Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS) was founded in 2018, with the aim to promote cooperation among vascular professionals within Mediterranean countries. Due to its prominent social and economic impact on national health systems, diabetic peripheral artery was selected as the very first topic to be investigated by the federation. In this second paper, different experiences from delegates of participating countries were shared to define common strategies to harmonize, standardize, and optimize education and training in the Vascular Surgery specialty
Microbial shifts in the aging mouse gut
YesBackground: The changes that occur in the microbiome of aging individuals are unclear, especially in light of the
imperfect correlation of frailty with age. Studies in older human subjects have reported subtle effects, but these
results may be confounded by other variables that often change with age such as diet and place of residence. To
test these associations in a more controlled model system, we examined the relationship between age, frailty, and
the gut microbiome of female C57BL/6 J mice.
Results: The frailty index, which is based on the evaluation of 31 clinical signs of deterioration in mice, showed a
near-perfect correlation with age. We observed a statistically significant relationship between age and the taxonomic
composition of the corresponding microbiome. Consistent with previous human studies, the Rikenellaceae family,
which includes the Alistipes genus, was the most significantly overrepresented taxon within middle-aged and
older mice.
The functional profile of the mouse gut microbiome also varied with host age and frailty. Bacterial-encoded
functions that were underrepresented in older mice included cobalamin (B12) and biotin (B7) biosynthesis,
and bacterial SOS genes associated with DNA repair. Conversely, creatine degradation, associated with muscle wasting,
was overrepresented within the gut microbiomes of the older mice, as were bacterial-encoded β-glucuronidases, which
can influence drug-induced epithelial cell toxicity. Older mice also showed an overabundance of monosaccharide
utilization genes relative to di-, oligo-, and polysaccharide utilization genes, which may have a substantial impact on
gut homeostasis.
Conclusion: We have identified taxonomic and functional patterns that correlate with age and frailty in the mouse
microbiome. Differences in functions related to host nutrition and drug pharmacology vary in an age-dependent
manner, suggesting that the availability and timing of essential functions may differ significantly with age and frailty.
Future work with larger cohorts of mice will aim to separate the effects of age and frailty, and other factors.This work was supported by the Canadian Institutes of Health Research (CIHR) through an Emerging Team Grant to RGB, CIHR Operating Grants to Langille et al. Microbiome 2014, 2:50 Page 10 of 12 http://www.microbiomejournal.com/content/2/1/50 SEH (MOP 126018) and RAR (MOP 93718), and a CIHR Fellowship to MGIL. Infrastructure was supported by the Canada Foundation for Innovation through a grant to RGB. RGB also acknowledges the support of the Canada Research Chairs program
Jefferson Community and Techincal College: Fall 2009 Spatial Analysis of Students
In this 43-page report, Jefferson Community and Technical College aimed to analyze student enrollment and residential data from 2009 along with data from the 2000 Census. According to the report, &quot;the initial task was to graphically represent the residential location for each student who was enrolled at Jefferson during the target semester, the results were geocoded against the ESRI Street Map at an 83% level with 1% tying which were also displayed, a total of 12,237 out of a total of 14,549 potential students were geographically referenced.&quot; The appendices at the end of the report contain the maps from the report in a larger view for further detailed examination
- …